Clinical and experimental pharmacokinetic interaction between 6-mercaptopurine and methotrexate

This publication has 35 references indexed in Scilit:

• Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy
  The Lancet, 1991
• Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia
  The Lancet, 1990
• 6-Mercaptopurine Plasma Levels in Children with Acute Lymphoblastic Leukemia
  Therapeutic Drug Monitoring, 1989
• Large Interindividual Variations in the Pharmacokinetics of Oral 6‐Mercaptopurine in Maintenance Therapy of Children with Acute Leukaemia and Non‐Hodgkin Lymphoma
  Acta Paediatrica, 1986
• Influence of Food Intake on Bioavailability of Oral 6-Mercaptopurine in Children with Acute Lymphoblastic Leukemia
  Pediatric Hematology and Oncology, 1986
• Analysis of 6-Mercaptopurine in Serum or Plasma Using High Performance Liquid Chromatography
  Therapeutic Drug Monitoring, 1985
• Variable Bioavailability of Oral Mercaptopurine
  New England Journal of Medicine, 1983
• THE TREATMENT OF ACUTE LYMPHOBLASTIC LEUKAEMIA
  British Journal of Haematology, 1980
• Enhanced 5-Fluorouracil Nucleotide Formation After Methotrexate Administration: Explanation for Drug Synergism
  Science, 1979
• IMMUNODEPRESSANT ACTIVITY AND 6-MERCAPTOPURINE LEVELS AFTER ADMINISTRATION OF 6-MERCAPTOPURINE AND AZATHIOPRINE
  Transplantation, 1973